Successful use of brentuximab vedotin for refractory anaplastic large cell lymphoma as a bridging therapy to haploidentical stem cell transplantation and maintenance therapy post‐transplantation

Publisher： John Wiley & Sons Inc

E-ISSN： 1545-5017|62|6|1063-1065

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.62, Iss.6, 2015-06, pp. : 1063-1065

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Brentuximab vedotin is an effective therapy for CD30+ mycosis fungoides and cutaneous anaplastic large‐cell lymphoma: what is the cost?

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 177, Iss. 6, 2017-12 ,pp. : 1474-1475

John Wiley & Sons Inc

Access to resources Recommend Favorite

An overview of conditioning regimens for haploidentical stem cell transplantation with post‐transplantation cyclophosphamide

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 6, 2015-06 ,pp. : 541-548

John Wiley & Sons Inc

Access to resources Recommend Favorite

Haematopoietic stem cell transplantation for relapsed or refractory anaplastic large cell lymphoma: a study of children and adolescents in Japan

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 4, 2015-02 ,pp. : 557-563

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reduced-Intensity Allogeneic Stem Cell Transplantation for Co-Emergence of Chemotherapy-Refractory Follicular Lymphoma and Therapy-Related Myelodysplastic Syndrome

By  

Case Reports in Oncology, Vol. 7, Iss. 1, 2014-03 ,pp. : 188-194

Karger

Access to resources Recommend Favorite

Severe cytokine release syndrome after the first dose of Brentuximab Vedotin in a patient with relapsed systemic anaplastic large cell lymphoma (sALCL): a case report and review of literature

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 6, 2015-06 ,pp. : 554-557

John Wiley & Sons Inc

Access to resources Recommend Favorite